Acadian Asset Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.51M Buy
79,423
+41,527
+110% +$2.72M 0.01% 647
2026
Q1
$296K Buy
37,896
+20,461
+117% +$331K ﹤0.01% 1486
2025
Q4
$298K Buy
17,435
+16,518
+1,801% +$320K ﹤0.01% 1436
2025
Q3
$23K Sell
917
-5,636
-86% -$213K ﹤0.01% 1761
2025
Q2
$372K Buy
+6,553
New +$526K ﹤0.01% 1196

Other funds holding AGL

Acadian Asset Management's AGL Position: Q2 2026 in Review

Acadian Asset Management increased its Agilon Health (AGL) stake by 110% in Q2 2026, buying an estimated $2.72M and bringing the position to 79,423 shares worth $8.51M. The position accounts for 0.01% of the portfolio, ranked #647.

Acadian Asset Management first reported a position in AGL in Q2 2025 and has held it in 5 quarters since. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Acadian Asset Management held 79,423 shares of Agilon Health worth $8.51M as of Q2 2026.
  • Acadian Asset Management bought 41,527 Agilon Health shares in Q2 2026, an estimated $2.72M.
  • Agilon Health made up 0.01% of Acadian Asset Management's portfolio in Q2 2026, its #647 holding.
  • Acadian Asset Management first reported a position in Agilon Health in Q2 2025 and has held it in 5 quarters since.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.